Dermatology Therapeutics Drug Development Pipeline Review, 2016

  • ID: 4076962
  • Report
  • Region: Global
  • 432 Pages
  • GBI Research
1 of 4
Dermatological Conditions are One of the Most Common Types of Disorders Worldwide, and Approximately One-Third of the US Population Suffers from at Least One Active Skin Condition

Summary

Dermatological conditions are one of the most common types of disorders worldwide, and approximately one-third of the US population suffers from at least one active skin condition. For the past decades, the majority of the dermatology market has remained saturated with established and generic products. However, the clinical and commercial success of biologics in the treatment of psoriasis, as well as advancements in the understanding of the disease pathways of many dermatological conditions, have led to a renewed interest from pharmaceutical companies in the dermatology market, and subsequently the emergence of an innovative pipeline.

There are over 800 products in active development in the dermatology therapy area, with the majority of products being small molecules. Biologics represent approximately 40% of the pipeline, despite the fact that this molecule type represents only a small fraction of the marketed products landscape.

Overall, the dermatology pipeline is highly innovative, owing to the advancements in the understanding of the disease pathways of many skin disorders. The number of strong late-stage products and substantial early-stage segment of this active and diverse pipeline are strong indicators of long-term growth in this market.

The report provides comprehensive information on the pipeline development landscape for is Acne vulgaris, Psoriasis and Atopic dermatitis, from Discovery through to the Pre-Registration stage. This includes an analysis of products by stage of development, molecular target, mechanism of action (MoA), route of administration (RoA) and molecule type. A list of all products in development is provided, including dormant and discontinued projects. Finally, the report provides an overview of key players involved in the development of products in this area, and outlines recent updates and press releases in the field.

Scope

  • Which companies are the most active within the pipeline for dermatology?
  • Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
  • To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
  • What are the most important R&D milestones and data publications to have happened in this disease area?

Reasons to buy

  • Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
  • Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
  • Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
  • Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration
READ MORE
Note: Product cover images may vary from those shown
2 of 4

1. Research Report Guidance

2. Executive Summary

3. Introduction

4. Research Report Coverage

  • Acne Vulgaris Overview
  • Psoriasis Overview
  • Atopic Dermatitis Overview
  • Therapeutics Development
  • Acne Vulgaris
  • Psoriasis
  • Atopic Dermatitis
  • Therapeutics under Development by Companies
  • Acne Vulgaris
  • Psoriasis
  • Atopic Dermatitis
  • Therapeutics under Investigation by Universities/Institutes
  • Acne Vulgaris
  • Psoriasis
  • Atopic Dermatitis
  • Pipeline Products Glance
  • Acne Vulgaris
  • Psoriasis
  • Atopic Dermatitis
  • Products under Development by Companies
  • Acne Vulgaris
  • Psoriasis
  • Atopic Dermatitis
  • Products under Investigation by Universities/Institutes
  • Acne Vulgaris
  • Psoriasis
  • Atopic Dermatitis
  • Companies Involved in Therapeutics Development
  • Acne Vulgaris
  • Psoriasis
  • Atopic Dermatitis
  • Therapeutics Assessment
  • Acne Vulgaris
  • Psoriasis
  • Atopic Dermatitis
  • Dormant Projects
  • Acne Vulgaris
  • Psoriasis
  • Atopic Dermatitis
  • Discontinued Products
  • Acne Vulgaris
  • Psoriasis
  • Atopic Dermatitis
  • Product Development Milestones
  • Acne Vulgaris
  • Psoriasis
  • Atopic Dermatitis

5. Appendix

  • Methodology
  • Coverage
  • Secondary Research
  • Primary Research
  • Expert Panel Validation

List of Tables

  • Number of Products under Development for Acne Vulgaris
  • Number of Products under Development for Acne Vulgaris - Comparative Analysis
  • Number of Products under Development for Psoriasis
  • Number of Products under Development for Psoriasis - Comparative Analysis
  • Number of Products under Development for Atopic Dermatitis
  • Number of Products under Development for Atopic Dermatitis - Comparative Analysis
  • Number of Products under Development by Companies
  • Number of Products under Development by Companies
  • Number of Products under Development by Companies
  • Number of Products under Investigation by Universities/Institutes
  • Number of Products under Investigation by Universities/Institutes
  • Number of Products under Investigation by Universities/Institutes
  • Number of Products under Investigation by Universities/Institutes
  • Comparative Analysis by Late Stage Development
  • Comparative Analysis by Clinical Stage Development
  • Comparative Analysis by Early Stage Development
  • Comparative Analysis by Late Stage Development
  • Comparative Analysis by Clinical Stage Development
  • Comparative Analysis by Early Stage Development
  • Comparative Analysis by Unknown Stage Development
  • Comparative Analysis by Late Stage Development
  • Comparative Analysis by Clinical Stage Development
  • Comparative Analysis by Early Stage Development
  • Products under Development by Companies
  • Products under Development by Companies
  • Products under Development by Companies
  • Products under Investigation by Universities/Institutes
  • Products under Investigation by Universities/Institutes
  • Products under Investigation by Universities/Institutes
  • Acne Vulgaris - Pipeline by 3SBio Inc
  • Acne Vulgaris - Pipeline by Allergan Plc
  • Acne Vulgaris - Pipeline by Almirall SA
  • Acne Vulgaris - Pipeline by Antibiotx ApS
  • Acne Vulgaris - Pipeline by Biomar Microbial Technologies
  • Acne Vulgaris - Pipeline by BioPharmX Inc
  • Acne Vulgaris - Pipeline by Braintree Laboratories Inc
  • Acne Vulgaris - Pipeline by Brickell Biotech Inc
  • Acne Vulgaris - Pipeline by Cell Medica Ltd
  • Acne Vulgaris - Pipeline by Cellceutix Corp
  • Acne Vulgaris - Pipeline by Celtaxsys Inc
  • Acne Vulgaris - Pipeline by Common Pharma Inc
  • Acne Vulgaris - Pipeline by Cutanea Life Sciences Inc
  • Acne Vulgaris - Pipeline by DermaXon LLC
  • Acne Vulgaris - Pipeline by Dermira Inc
  • Acne Vulgaris - Pipeline by ELORAC Inc
  • Acne Vulgaris - Pipeline by Ensol Biosciences Inc
  • Acne Vulgaris - Pipeline by Foamix Pharmaceuticals Ltd
  • Acne Vulgaris - Pipeline by Galderma SA
  • Acne Vulgaris - Pipeline by GlaxoSmithKline Plc
  • Acne Vulgaris - Pipeline by Helix BioMedix Inc
  • Acne Vulgaris - Pipeline by Hovione FarmaCiencia SA
  • Acne Vulgaris - Pipeline by Lee's Pharmaceutical Holdings Ltd
  • Acne Vulgaris - Pipeline by LEO Pharma A/S
  • Acne Vulgaris - Pipeline by Novabiotics Ltd
  • Acne Vulgaris - Pipeline by Novan Inc
  • Acne Vulgaris - Pipeline by Paratek Pharmaceuticals Inc
  • Acne Vulgaris - Pipeline by Pfizer Inc
  • Acne Vulgaris - Pipeline by Phosphagenics Ltd
  • Acne Vulgaris - Pipeline by Photocure ASA
  • Acne Vulgaris - Pipeline by Promius Pharma LLC
  • Acne Vulgaris - Pipeline by Provectus Biopharmaceuticals Inc
  • Acne Vulgaris - Pipeline by Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
  • Acne Vulgaris - Pipeline by Sol-Gel Technologies Ltd
  • Acne Vulgaris - Pipeline by Sun Pharma Advanced Research Company Ltd
  • Acne Vulgaris - Pipeline by Telesso Technologies Ltd
  • Acne Vulgaris - Pipeline by Thesan Pharmaceuticals Inc
  • Acne Vulgaris - Pipeline by Valeant Pharmaceuticals International Inc
  • Acne Vulgaris - Pipeline by Vectura Group Plc
  • Acne Vulgaris - Pipeline by Vyome Biosciences Pvt Ltd
  • Acne Vulgaris - Pipeline by XBiotech Inc
  • Acne Vulgaris - Pipeline by Xenon Pharmaceuticals Inc
  • Psoriasis - Pipeline by AbbVie Inc
  • Psoriasis - Pipeline by Abeome Corp
  • Psoriasis - Pipeline by AbGenomics International Inc
  • Psoriasis - Pipeline by Addex Therapeutics Ltd
  • Psoriasis - Pipeline by Adello Biologics LLC
  • Psoriasis - Pipeline by Advinus Therapeutics Ltd
  • Psoriasis - Pipeline by Affibody AB
  • Psoriasis - Pipeline by Albireo Pharma Inc
  • Psoriasis - Pipeline by Alfacyte Ltd
  • Psoriasis - Pipeline by Almirall SA
  • Psoriasis - Pipeline by Alteogen Inc
  • Psoriasis - Pipeline by Amgen Inc
  • Psoriasis - Pipeline by Anacor Pharmaceuticals Inc
  • Psoriasis - Pipeline by AnaptysBio Inc
  • Psoriasis - Pipeline by ApoPharma Inc
  • Psoriasis - Pipeline by Arena Pharmaceuticals Inc
  • Psoriasis - Pipeline by Argos Therapeutics Inc
  • Psoriasis - Pipeline by Arrien Pharmaceuticals LLC
  • Psoriasis - Pipeline by AstraZeneca Plc
  • Psoriasis - Pipeline by Athenex Inc
  • Psoriasis - Pipeline by Atlantic Bio Sci LLC
  • Psoriasis - Pipeline by Aurigene Discovery Technologies Ltd
  • Psoriasis - Pipeline by Aurinia Pharmaceuticals Inc
  • Psoriasis - Pipeline by Avexxin AS
  • Psoriasis - Pipeline by Bayer AG
  • Psoriasis - Pipeline by Betta Pharmaceuticals Co Ltd
  • Psoriasis - Pipeline by BioApex sro
  • Psoriasis - Pipeline by Biocad
  • Psoriasis - Pipeline by Biocon Ltd
  • Psoriasis - Pipeline by BioLingus AG
  • Psoriasis - Pipeline by BioMAS Ltd
  • Psoriasis - Pipeline by Biomics Biotechnologies Co Ltd
  • Psoriasis - Pipeline by Bionomics Ltd
  • Psoriasis - Pipeline by Bionovis SA
  • Psoriasis - Pipeline by BirchBioMed Inc
  • Psoriasis - Pipeline by Boehringer Ingelheim GmbH
  • Psoriasis - Pipeline by Brickell Biotech Inc
  • Psoriasis - Pipeline by Bristol-Myers Squibb Company
  • Psoriasis - Pipeline by C4X Discovery Holdings PLC
  • Psoriasis - Pipeline by CalciMedica Inc
  • Psoriasis - Pipeline by Can-Fite BioPharma Ltd
  • Psoriasis - Pipeline by Celgene Corp
  • Psoriasis - Pipeline by Cell Medica Ltd
  • Psoriasis - Pipeline by Cellceutix Corp
  • Psoriasis - Pipeline by ChemoCentryx Inc
  • Psoriasis - Pipeline by Chipscreen Biosciences Ltd
  • Psoriasis - Pipeline by ChironWells GmbH
  • Psoriasis - Pipeline by Coherus BioSciences Inc
  • Psoriasis - Pipeline by Compugen Ltd
  • Psoriasis - Pipeline by Convoy Therapeutics Inc
  • Psoriasis - Pipeline by Creabilis SA
  • Psoriasis - Pipeline by Crescendo Biologics Ltd
  • Psoriasis - Pipeline by Curapel Ltd
  • Psoriasis - Pipeline by Cutanea Life Sciences Inc
  • Psoriasis - Pipeline by Dermala Inc
  • Psoriasis - Pipeline by Domainex Ltd
  • Psoriasis - Pipeline by Dr. August Wolff GmbH & Co KG Arzneimittle
  • Psoriasis - Pipeline by EA Pharma Co Ltd
  • Psoriasis - Pipeline by Eli Lilly and Company
  • Psoriasis - Pipeline by ELORAC Inc
  • Psoriasis - Pipeline by Exicure Inc
  • Psoriasis - Pipeline by Foamix Pharmaceuticals Ltd
  • Psoriasis - Pipeline by Forward Pharma A/S
  • Psoriasis - Pipeline by Gem Pharmaceuticals LLC
  • Psoriasis - Pipeline by Genentech Inc
  • Psoriasis - Pipeline by Genor BioPharma Co Ltd
  • Psoriasis - Pipeline by GlaxoSmithKline Plc
  • Psoriasis - Pipeline by GlycoMar Ltd
  • Psoriasis - Pipeline by Grupo Ferrer Internacional SA
  • Psoriasis - Pipeline by HitGen LTD
  • Psoriasis - Pipeline by Huabo Biopharm Co Ltd
  • Psoriasis - Pipeline by Hydra Biosciences Inc
  • Psoriasis - Pipeline by iCo Therapeutics Inc.
  • Psoriasis - Pipeline by Idera Pharmaceuticals Inc
  • Psoriasis - Pipeline by Iltoo Pharma
  • Psoriasis - Pipeline by Immune Pharmaceuticals Inc
  • Psoriasis - Pipeline by Immune Response BioPharma Inc
  • Psoriasis - Pipeline by Immungenetics AG
  • Psoriasis - Pipeline by Innovent Biologics Inc
  • Psoriasis - Pipeline by Jenrin Discovery Inc
  • Psoriasis - Pipeline by Jiangsu Hengrui Medicine Co Ltd
  • Psoriasis - Pipeline by Johnson & Johnson
  • Psoriasis - Pipeline by Kadmon Corp LLC
  • Psoriasis - Pipeline by KaloBios Pharmaceuticals Inc
  • Psoriasis - Pipeline by Kang Stem Biotech Co Ltd
  • Psoriasis - Pipeline by KPI Therapeutics Inc
  • Psoriasis - Pipeline by Lead Pharma Holding BV
  • Psoriasis - Pipeline by Lee's Pharmaceutical Holdings Ltd
  • Psoriasis - Pipeline by LEO Pharma A/S
  • Psoriasis - Pipeline by Lipidor AB
  • Psoriasis - Pipeline by Lupin Ltd
  • Psoriasis - Pipeline by Lycera Corp
  • Psoriasis - Pipeline by mAbxience SA
  • Psoriasis - Pipeline by Maruho Co Ltd
  • Psoriasis - Pipeline by Medestea Research & Production SpA
  • Psoriasis - Pipeline by MediGene AG
  • Psoriasis - Pipeline by Merck KGaA
  • Psoriasis - Pipeline by MetrioPharm AG
  • Psoriasis - Pipeline by Mitsubishi Tanabe Pharma Corp
  • Psoriasis - Pipeline by Momenta Pharmaceuticals Inc
  • Psoriasis - Pipeline by Mycenax Biotech Inc
  • Psoriasis - Pipeline by NeuClone Pty Ltd
  • Psoriasis - Pipeline by Nimbus Therapeutics LLC
  • Psoriasis - Pipeline by NovaLead Pharma Pvt Ltd
  • Psoriasis - Pipeline by Novan Inc
  • Psoriasis - Pipeline by Novartis AG
  • Psoriasis - Pipeline by Nuevolution AB
  • Psoriasis - Pipeline by Numedii Inc
  • Psoriasis - Pipeline by Oncobiologics Inc
  • Psoriasis - Pipeline by OSE Immunotherapeutics
  • Psoriasis - Pipeline by Panacea Biotec Ltd
  • Psoriasis - Pipeline by Pfizer Inc
  • Psoriasis - Pipeline by Pharis Biotec GmbH
  • Psoriasis - Pipeline by Pharmedartis GmbH
  • Psoriasis - Pipeline by Pieris Pharmaceuticals Inc
  • Psoriasis - Pipeline by PinCell srl
  • Psoriasis - Pipeline by Promius Pharma LLC
  • Psoriasis - Pipeline by Protalix BioTherapeutics Inc
  • Psoriasis - Pipeline by Prothena Corp Plc
  • Psoriasis - Pipeline by Provectus Biopharmaceuticals Inc
  • Psoriasis - Pipeline by RedHill Biopharma Ltd
  • Psoriasis - Pipeline by Reliance Life Sciences Pvt Ltd
  • Psoriasis - Pipeline by Samumed LLC
  • Psoriasis - Pipeline by Sandoz International GmbH
  • Psoriasis - Pipeline by Sareum Holdings Plc
  • Psoriasis - Pipeline by Selvita SA
  • Psoriasis - Pipeline by Shanghai Celgen Bio-Pharmaceutical Co Ltd
  • Psoriasis - Pipeline by Shulov Innovative Science Ltd
  • Psoriasis - Pipeline by Sigmoid Pharma Ltd
  • Psoriasis - Pipeline by Soligenix Inc
  • Psoriasis - Pipeline by Spherium Biomed SL
  • Psoriasis - Pipeline by Stemline Therapeutics Inc
  • Psoriasis - Pipeline by sterna biologicals Gmbh & Co KG
  • Psoriasis - Pipeline by Sucampo Pharmaceuticals Inc
  • Psoriasis - Pipeline by Sun Pharma Advanced Research Company Ltd
  • Psoriasis - Pipeline by SWITCH Biotech LLC
  • Psoriasis - Pipeline by Takeda Pharmaceutical Company Ltd
  • Psoriasis - Pipeline by Tasly Pharmaceutical Group Co Ltd
  • Psoriasis - Pipeline by Telormedix SA
  • Psoriasis - Pipeline by Teva Pharmaceutical Industries Ltd
  • Psoriasis - Pipeline by TheraMAB LLC
  • Psoriasis - Pipeline by Therapix Biosciences Ltd
  • Psoriasis - Pipeline by UCB SA
  • Psoriasis - Pipeline by Valeant Pharmaceuticals International Inc
  • Psoriasis - Pipeline by Vitae Pharmaceuticals Inc
  • Psoriasis - Pipeline by Wellstat Therapeutics Corp
  • Psoriasis - Pipeline by XBiotech Inc
  • Psoriasis - Pipeline by XenoPort Inc
  • Psoriasis - Pipeline by Yuhan Corp
  • Psoriasis - Pipeline by Ziarco Pharma Ltd
  • Atopic Dermatitis - Pipeline by AbbVie Inc
  • Atopic Dermatitis - Pipeline by Abeome Corp
  • Atopic Dermatitis - Pipeline by Accolade Pharmaceuticals LLC
  • Atopic Dermatitis - Pipeline by Albireo Pharma Inc
  • Atopic Dermatitis - Pipeline by Almirall SA
  • Atopic Dermatitis - Pipeline by Amgen Inc
  • Atopic Dermatitis - Pipeline by Amorepacific Corp
  • Atopic Dermatitis - Pipeline by Anacor Pharmaceuticals Inc
  • Atopic Dermatitis - Pipeline by AnaMar AB
  • Atopic Dermatitis - Pipeline by AnaptysBio Inc
  • Atopic Dermatitis - Pipeline by AnGes MG Inc
  • Atopic Dermatitis - Pipeline by Avexxin AS
  • Atopic Dermatitis - Pipeline by Blueberry Therapeutics Ltd
  • Atopic Dermatitis - Pipeline by Brickell Biotech Inc
  • Atopic Dermatitis - Pipeline by Celgene Corp
  • Atopic Dermatitis - Pipeline by Cell Medica Ltd
  • Atopic Dermatitis - Pipeline by Cellceutix Corp
  • Atopic Dermatitis - Pipeline by ChemoCentryx Inc
  • Atopic Dermatitis - Pipeline by ChironWells GmbH
  • Atopic Dermatitis - Pipeline by Chugai Pharmaceutical Co Ltd
  • Atopic Dermatitis - Pipeline by Clevexel Pharma SA
  • Atopic Dermatitis - Pipeline by Creabilis SA
  • Atopic Dermatitis - Pipeline by Curapel Ltd
  • Atopic Dermatitis - Pipeline by Cutanea Life Sciences Inc
  • Atopic Dermatitis - Pipeline by Dermala Inc
  • Atopic Dermatitis - Pipeline by Dr. August Wolff GmbH & Co KG Arzneimittle
  • Atopic Dermatitis - Pipeline by Eli Lilly and Company
  • Atopic Dermatitis - Pipeline by F. Hoffmann-La Roche Ltd
  • Atopic Dermatitis - Pipeline by Foamix Pharmaceuticals Ltd
  • Atopic Dermatitis - Pipeline by Fountain Biopharma Inc
  • Atopic Dermatitis - Pipeline by Galapagos NV
  • Atopic Dermatitis - Pipeline by GlaxoSmithKline Plc
  • Atopic Dermatitis - Pipeline by Glenmark Pharmaceuticals Ltd
  • Atopic Dermatitis - Pipeline by Grupo Ferrer Internacional SA
  • Atopic Dermatitis - Pipeline by Han Wha Pharma Co Ltd
  • Atopic Dermatitis - Pipeline by HanAll Biopharma Co Ltd
  • Atopic Dermatitis - Pipeline by Heptares Therapeutics Ltd
  • Atopic Dermatitis - Pipeline by Herantis Pharma Plc
  • Atopic Dermatitis - Pipeline by iCo Therapeutics Inc.
  • Atopic Dermatitis - Pipeline by Immune Pharmaceuticals Inc
  • Atopic Dermatitis - Pipeline by Inflamalps SA
  • Atopic Dermatitis - Pipeline by Japan Tobacco Inc
  • Atopic Dermatitis - Pipeline by Johnson & Johnson
  • Atopic Dermatitis - Pipeline by Kang Stem Biotech Co Ltd
  • Atopic Dermatitis - Pipeline by KPI Therapeutics Inc
  • Atopic Dermatitis - Pipeline by LEO Pharma A/S
  • Atopic Dermatitis - Pipeline by Madam Therapeutics BV
  • Atopic Dermatitis - Pipeline by MedImmune LLC
  • Atopic Dermatitis - Pipeline by Mitsubishi Tanabe Pharma Corp
  • Atopic Dermatitis - Pipeline by NeoPharm Co Ltd
  • Atopic Dermatitis - Pipeline by Novan Inc
  • Atopic Dermatitis - Pipeline by Novartis AG
  • Atopic Dermatitis - Pipeline by Orbis Biosciences Inc
  • Atopic Dermatitis - Pipeline by Otsuka Holdings Co Ltd
  • Atopic Dermatitis - Pipeline by Oxagen Ltd
  • Atopic Dermatitis - Pipeline by Pfizer Inc
  • Atopic Dermatitis - Pipeline by Pharis Biotec GmbH
  • Atopic Dermatitis - Pipeline by Pharmedartis GmbH
  • Atopic Dermatitis - Pipeline by Provectus Biopharmaceuticals Inc
  • Atopic Dermatitis - Pipeline by PuriCore Plc
  • Atopic Dermatitis - Pipeline by Regeneron Pharmaceuticals Inc
  • Atopic Dermatitis - Pipeline by Roivant Sciences Ltd
  • Atopic Dermatitis - Pipeline by Signum Dermalogix Inc
  • Atopic Dermatitis - Pipeline by Spherium Biomed SL
  • Atopic Dermatitis - Pipeline by sterna biologicals Gmbh & Co KG
  • Atopic Dermatitis - Pipeline by Sucampo Pharmaceuticals Inc
  • Atopic Dermatitis - Pipeline by Sun Pharma Advanced Research Company Ltd
  • Atopic Dermatitis - Pipeline by SWITCH Biotech LLC
  • Atopic Dermatitis - Pipeline by Takeda Pharmaceutical Company Ltd
  • Atopic Dermatitis - Pipeline by Thesan Pharmaceuticals Inc
  • Atopic Dermatitis - Pipeline by Torrent Pharmaceuticals Ltd
  • Atopic Dermatitis - Pipeline by Trevi Therapeutics Inc
  • Atopic Dermatitis - Pipeline by Valeant Pharmaceuticals International Inc
  • Atopic Dermatitis - Pipeline by Vicore Pharma AB
  • Atopic Dermatitis - Pipeline by Vitae Pharmaceuticals Inc
  • Atopic Dermatitis - Pipeline by VivaCell Biotechnology Espana SL
  • Atopic Dermatitis - Pipeline by Xencor Inc
  • Atopic Dermatitis - Pipeline by Ziarco Pharma Ltd
  • Assessment by Monotherapy Products
  • Assessment by Combination Products
  • Number of Products by Stage and Target
  • Number of Products by Stage and Mechanism of Action
  • Number of Products by Stage and Route of Administration
  • Number of Products by Stage and Molecule Type
  • Assessment by Monotherapy Products
  • Assessment by Combination Products
  • Number of Products by Stage and Target
  • Number of Products by Stage and Mechanism of Action
  • Number of Products by Stage and Route of Administration
  • Number of Products by Stage and Molecule Type
  • Assessment by Monotherapy Products
  • Number of Products by Stage and Target
  • Number of Products by Stage and Mechanism of Action
  • Number of Products by Stage and Route of Administration
  • Number of Products by Stage and Molecule Type
  • Acne Vulgaris - Dormant Projects
  • Psoriasis - Dormant Projects
  • Atopic Dermatitis - Dormant Projects
  • Acne Vulgaris - Discontinued Products
  • Psoriasis - Discontinued Products
  • Atopic Dermatitis - Discontinued Products

List of Figures

  • Number of Products under Development for Acne Vulgaris
  • Number of Products under Development for Acne Vulgaris - Comparative Analysis
  • Number of Products under Development for Psoriasis
  • Number of Products under Development for Psoriasis - Comparative Analysis
  • Number of Products under Development for Atopic Dermatitis
  • Number of Products under Development for Atopic Dermatitis - Comparative Analysis
  • Number of Products under Development by Companies
  • Number of Products under Development by Companies
  • Number of Products under Development by Companies
  • Number of Products under Investigation by Universities/Institutes
  • Number of Products under Investigation by Universities/Institutes
  • Number of Products under Investigation by Universities/Institutes
  • Comparative Analysis by Late Stage Development
  • Comparative Analysis by Clinical Stage Development
  • Comparative Analysis by Early Stage Products
  • Comparative Analysis by Late Stage Development
  • Comparative Analysis by Clinical Stage Development
  • Comparative Analysis by Early Stage Products
  • Comparative Analysis by Late Stage Development
  • Comparative Analysis by Clinical Stage Development
  • Comparative Analysis by Early Stage Products
  • Assessment by Monotherapy Products
  • Assessment by Combination Products
  • Number of Products by Top 10 Targets
  • Number of Products by Stage and Top 10 Targets
  • Number of Products by Top 10 Mechanism of Actions
  • Number of Products by Stage and Top 10 Mechanism of Actions
  • Number of Products by Routes of Administration
  • Number of Products by Stage and Routes of Administration
  • Number of Products by Molecule Types
  • Number of Products by Stage and Molecule Types
  • Assessment by Monotherapy Products
  • Assessment by Combination Products
  • Number of Products by Top 10 Targets
  • Number of Products by Stage and Top 10 Targets
  • Number of Products by Top 10 Mechanism of Actions
  • Number of Products by Stage and Top 10 Mechanism of Actions
  • Number of Products by Top 10 Routes of Administration
  • Number of Products by Stage and Top 10 Routes of Administration
  • Number of Products by Top 10 Molecule Types
  • Number of Products by Stage and Top 10 Molecule Types
  • Assessment by Monotherapy Products
  • Number of Products by Top 10 Targets
  • Number of Products by Stage and Top 10 Targets
  • Number of Products by Top 10 Mechanism of Actions
  • Number of Products by Stage and Top 10 Mechanism of Actions
  • Number of Products by Top 10 Routes of Administration
  • Number of Products by Stage and Top 10 Routes of Administration
  • Number of Products by Top 10 Molecule Types
  • Number of Products by Stage and Top 10 Molecule Types
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll